Publication | Closed Access

Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment

InflammationHypertensionHeart FailureCardiovascular DiseasePhysiologyPharmacologyCardiovascular PharmacologyEndothelial DysfunctionEpirubicin-induced InflammationVascular BiologyPharmacotherapyProtective EffectsCardiovascular ToxicityMedicineOxidative Stress